These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 2250296)

  • 1. Ability of circular extrachromosomal DNA molecules to carry amplified MYCN proto-oncogenes in human neuroblastomas in vivo.
    VanDevanter DR; Piaskowski VD; Casper JT; Douglass EC; Von Hoff DD
    J Natl Cancer Inst; 1990 Dec; 82(23):1815-21. PubMed ID: 2250296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution mapping of a 130-kb core region of the MYCN amplicon in neuroblastomas.
    Reiter JL; Brodeur GM
    Genomics; 1996 Feb; 32(1):97-103. PubMed ID: 8786126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
    Bourhis J; De Vathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; McNally NJ; Lemerle J; Riou G; Bénard J
    Cancer Res; 1991 Jan; 51(1):33-6. PubMed ID: 1988094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
    Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
    Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid detection of MYCN gene amplification in neuroblastomas using the polymerase chain reaction.
    Crabbe DC; Peters J; Seeger RC
    Diagn Mol Pathol; 1992 Dec; 1(4):229-34. PubMed ID: 1342970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma.
    Manohar CF; Salwen HR; Brodeur GM; Cohn SL
    Genes Chromosomes Cancer; 1995 Nov; 14(3):196-203. PubMed ID: 8589036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeast artificial chromosome (YAC) vector cloning of the MYCN amplified domain in neuroblastomas.
    Schneider SS; Zehnbauer BA; Vogelstein B; Brodeur GM
    Prog Clin Biol Res; 1991; 366():71-6. PubMed ID: 2068181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of a DEAD box gene (DDX1) with the MYCN gene in neuroblastomas as a result of cosegregation of sequences flanking the MYCN locus.
    Noguchi T; Akiyama K; Yokoyama M; Kanda N; Matsunaga T; Nishi Y
    Genes Chromosomes Cancer; 1996 Feb; 15(2):129-33. PubMed ID: 8834177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare MYC-amplified Neuroblastoma With Large Cell Histology.
    Matsuno R; Gifford AJ; Fang J; Warren M; Lukeis RE; Trahair T; Sugimoto T; Marachelian A; Asgharzadeh S; Maris JM; Ikegaki N; Shimada H
    Pediatr Dev Pathol; 2018; 21(5):461-466. PubMed ID: 29426276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene amplification in human neuroblastomas: basic mechanisms and clinical implications.
    Brodeur GM; Seeger RC
    Cancer Genet Cytogenet; 1986 Jan; 19(1-2):101-11. PubMed ID: 3940169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amplification of N-myc in neuroblastoma: paradigm for clinical use of an oncogene alteration].
    Schwab M
    Klin Padiatr; 1990; 202(4):197-201. PubMed ID: 2203936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of MYCN amplification in three neuroblastoma cell lines by non-radioactive chromosomal in situ hybridization.
    McRobert TL; Rudduck C; Kees UR; Garson OM
    Cancer Genet Cytogenet; 1992 Apr; 59(2):128-34. PubMed ID: 1581879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.
    Wang Q; Hii G; Shusterman S; Mosse Y; Winter CL; Guo C; Zhao H; Rappaport E; Hogarty MD; Maris JM
    Cancer Res; 2003 Apr; 63(7):1631-5. PubMed ID: 12670915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma.
    Corvi R; Savelyeva L; Breit S; Wenzel A; Handgretinger R; Barak J; Oren M; Amler L; Schwab M
    Oncogene; 1995 Mar; 10(6):1081-6. PubMed ID: 7700632
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Zimmerman MW; Liu Y; He S; Durbin AD; Abraham BJ; Easton J; Shao Y; Xu B; Zhu S; Zhang X; Li Z; Weichert-Leahey N; Young RA; Zhang J; Look AT
    Cancer Discov; 2018 Mar; 8(3):320-335. PubMed ID: 29284669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
    Nakagawa A; Matsuoka K; Okita H; Iwafuchi H; Hori H; Kumagai M
    Pediatr Dev Pathol; 2011; 14(2):87-92. PubMed ID: 21288077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYCN is the only highly expressed gene from the core amplified domain in human neuroblastomas.
    Reiter JL; Brodeur GM
    Genes Chromosomes Cancer; 1998 Oct; 23(2):134-40. PubMed ID: 9739016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of unfavorable histology, MYCN amplification and diploidy for stage I and II neuroblastomas.
    de Buys Roessingh AS; Rougemont AL; Wiesenauer C; Barrette S; Bouron-Dal Soglio D; Lallier M
    Eur J Pediatr Surg; 2008 Dec; 18(6):410-4. PubMed ID: 19012235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
    Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
    J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification.
    Liu X; Mazanek P; Dam V; Wang Q; Zhao H; Guo R; Jagannathan J; Cnaan A; Maris JM; Hogarty MD
    Oncogene; 2008 Feb; 27(10):1478-88. PubMed ID: 17724465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.